You are here



The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

29 July 2014

AIDS 2014: Reflections on the Conference

Reflections on the International AIDS Conference 2014 (AIDS 2014) from Caitlin Mahon - AVERT's Research and Information Officer who attended the conference last week.

28 July 2014

World Hepatitis Day: Antiretroviral drug also benefits the treatment of hepatitis C

July 28th is World Hepatitis Day, which aims to raise awareness of viral hepatitis around the world. There are five main types of hepatitis virus, referred to as types A, B, C, D and E. Hepatitis C is considered to be causing a “dual epidemic” with HIV because it is highly prevalent in HIV-endemic areas. About five million people living with HIV, or 15% of the total, are co-infected with hepatitis C.

26 July 2014

Taiwan lifts travel ban for people living with HIV

Taiwan has lifted the ban on entry, stay and residence of foreigners living with HIV, as reported in the Taipei Times last week. The new law states that people wishing to stay in Taiwan for more than three months are no longer required to produce a recent HIV test, nor do they risk being deported or having their visas revoked if they find that they are living with HIV.

25 July 2014

National AIDS strategic plans failing to include young key populations

A new report about the inclusion of young key populations in strategic plans in the Asia-Pacific Regional has been released at the 2014 International AIDS conference.

24 July 2014

Study suggests decriminalising sex work could dramatically reduce HIV infections

A new study presented at the 2014 International AIDS Conference has found that decriminalising sex work could reduce HIV infections by 33-46 percent over the next 10 years. Published in the Lancet’s new series, HIV and Sex Workers, the study researched HIV among female sex workers (FSW) across Canada, India and Kenya.

22 July 2014

Breakthrough in multi-drug resistant TB treatment

At the first day of the 20th International AIDS Conference a major breakthrough in treatment of tuberculosis (TB) has been announced. Experiments with a new cocktail of three drugs to treat patients infected with TB strains that are hard to cure with conventional antibiotics, can not only improve the treatment of TB and its multi-drug resistant strains, but also shorten the treatment period.

21 July 2014

AVERT pays tribute to colleagues lost on MH17 flight

AVERT shares its condolences and deepest sympathies for the tragic loss of life due to the crash of flight MH17. Our thoughts are with the families, friends and dear colleagues of those who have died. We pay tribute to those who were flying to attend the AIDS 2014 conference and recognise their invaluable contribution to the HIV response.

18 July 2014

UNAIDS GAP report calls for greater focus on people left behind

Ahead of the International AIDS Conference (AIDS2014), UNAIDS has released a major report emphasising the progress and highlighting the gaps in the global response to HIV. While many people have benefited from the response, leading to a 38 percent reduction in the number of new infections between 2001 and 2013, not all populations have benefited equally.

15 July 2014

New WHO guidelines recommend PrEP for all MSM

Prior to the start of the 2014 International AIDS conference in Melbourne, the World Health Organisation (WHO) has published their first consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations.

14 July 2014

Addressing stigma and discrimination through faith leaders

The 20th International AIDS Conference (AIDS 2014) is being held this year in Melbourne, Australia, from July 20-25th. The biannual conference is one of the most important events in the HIV calendar, and gives an opportunity for a diverse range of voices to come together, share experiences and drive forward positive change for the HIV epidemic. This guest blog series will include reflections from key organisations working in the field of HIV - the HIV/AIDS Alliance, STOPAIDS, CAFOD and Save the Children.